Function Health raised $450 million in a growth financing round, announced on August 14, 2026 and led by General Catalyst. The raise comes just eight months after its Series B, underscoring how much capital is chasing the shift from reactive treatment to preventive, AI-driven diagnostics.
Here's the full breakdown of the raise and what it means for preventive healthcare.
What is Function Health?
Function Health is an AI-driven preventive healthcare platform. It analyzes more than 160 biomarker tests along with medical imaging to flag disease early, delivered to consumers through a membership model. Founded in 2022, the company's premise is that continuous, broad-panel testing combined with AI analysis can catch health problems years before symptoms would otherwise prompt a doctor's visit.
The raise: $450M growth round
The headline numbers:
- Amount: $450 million
- Round: Growth
- Announced: August 14, 2026
- Lead investor: General Catalyst
Function Health's previous raise was a $298 million Series B just eight months earlier, in December 2025. With this round, total funding now approaches $800 million — a pace of fundraising that reflects strong underlying revenue growth rather than just investor enthusiasm.
Who invested in Function Health?
The growth round was led by General Catalyst. No co-leads or additional participants were disclosed for this round.
What Function Health will do with the money
The company says the funding will go toward scaling preventive screening, expanding biomarker analysis, and deepening its AI diagnostic capabilities — effectively growing both the breadth of what it tests for and the sophistication of the AI that interprets those results.
Why it matters
Function Health's raise reflects two forces converging in consumer healthcare:
- Preventive, consumer-paid healthcare is becoming a real business, not a niche. Function Health is approaching $1 billion in annualized revenue, which validates that consumers will pay out of pocket for earlier, more frequent health monitoring rather than waiting for insurance-driven, symptom-triggered care.
- Capital is compounding quickly for proven preventive-health platforms. Raising $450 million just eight months after a $298 million round, and nearing $800 million in total funding, shows investors backing revenue growth with speed rather than waiting for a traditional 12-to-18-month gap between rounds.
- AI-driven diagnostics is attracting competition across price points. Function Health's growth round lands alongside other AI-powered preventive health platforms like Neko Health, pointing to a broader race to own the "annual health scan" category before it consolidates.
Source: Function Health Secures $450M Growth Financing for Preventive Care Platform
Following AI funding? Wortins tracks the biggest raises, valuations, and acquisitions daily in the AI Funding Tracker.